These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Review of current guidelines on the care of postherpetic neuralgia. Argoff CE Postgrad Med; 2011 Sep; 123(5):134-42. PubMed ID: 21904096 [TBL] [Abstract][Full Text] [Related]
3. Tolerability of treatments for postherpetic neuralgia. Douglas MW; Johnson RW; Cunningham AL Drug Saf; 2004; 27(15):1217-33. PubMed ID: 15588117 [TBL] [Abstract][Full Text] [Related]
4. Postherpetic neuralgia: role of gabapentin and other treatment modalities. Beydoun A Epilepsia; 1999; 40 Suppl 6():S51-6; discussion S73-4. PubMed ID: 10530683 [TBL] [Abstract][Full Text] [Related]
5. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings. Gore M; Sadosky A; Tai KS; Stacey B Clin Ther; 2007 Aug; 29(8):1655-70. PubMed ID: 17919547 [TBL] [Abstract][Full Text] [Related]
6. [Development of animal models of herpetic pain and postherpetic neuralgia and elucidation of the mechanisms of the onset and inhibition of allodynia]. Takasaki I Yakugaku Zasshi; 2011 Feb; 131(2):299-306. PubMed ID: 21297375 [TBL] [Abstract][Full Text] [Related]
7. Gabapentin versus tricyclic antidepressants for diabetic neuropathy and post-herpetic neuralgia: discrepancies between direct and indirect meta-analyses of randomized controlled trials. Chou R; Carson S; Chan BK J Gen Intern Med; 2009 Feb; 24(2):178-88. PubMed ID: 19089502 [TBL] [Abstract][Full Text] [Related]
12. Gabapentin for once-daily treatment of post-herpetic neuralgia: a review. Beal B; Moeller-Bertram T; Schilling JM; Wallace MS Clin Interv Aging; 2012; 7():249-55. PubMed ID: 22866002 [TBL] [Abstract][Full Text] [Related]
13. Postherpetic Neuralgia: Current Evidence on the Topical Film-Forming Spray with Bupivacaine Hydrochloride and a Review of Available Treatment Strategies. Ngo AL; Urits I; Yilmaz M; Fortier L; Anya A; Oh JH; Berger AA; Kassem H; Sanchez MG; Kaye AD; Urman RD; Herron EW; Cornett EM; Viswanath O Adv Ther; 2020 May; 37(5):2003-2016. PubMed ID: 32297285 [TBL] [Abstract][Full Text] [Related]
14. Management of herpes zoster and post-herpetic neuralgia. Gan EY; Tian EA; Tey HL Am J Clin Dermatol; 2013 Apr; 14(2):77-85. PubMed ID: 23456596 [TBL] [Abstract][Full Text] [Related]
15. Pregabalin: new drug. Very similar to gabapentin. Prescrire Int; 2005 Dec; 14(80):203-6. PubMed ID: 16397976 [TBL] [Abstract][Full Text] [Related]
16. An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy. Zin CS; Nissen LM; Smith MT; O'Callaghan JP; Moore BJ CNS Drugs; 2008; 22(5):417-42. PubMed ID: 18399710 [TBL] [Abstract][Full Text] [Related]
17. Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial--the GONIP Trial. Chandra K; Shafiq N; Pandhi P; Gupta S; Malhotra S Int J Clin Pharmacol Ther; 2006 Aug; 44(8):358-63. PubMed ID: 16961166 [TBL] [Abstract][Full Text] [Related]
18. Treatment of postherpetic neuralgia. Menke JJ; Heins JR J Am Pharm Assoc (Wash); 1999; 39(2):217-21. PubMed ID: 10079653 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of a lidocaine 5% medicated plaster relative to gabapentin for postherpetic neuralgia in the United Kingdom. Dakin H; Nuijten M; Liedgens H; Nautrup BP Clin Ther; 2007 Jul; 29(7):1491-507. PubMed ID: 17825701 [TBL] [Abstract][Full Text] [Related]
20. 5% lidocaine-medicated plaster vs other relevant interventions and placebo for post-herpetic neuralgia (PHN): a systematic review. Wolff RF; Bala MM; Westwood M; Kessels AG; Kleijnen J Acta Neurol Scand; 2011 May; 123(5):295-309. PubMed ID: 21039364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]